Gastroretentive Orlistat Microspheres: Formulation, Characterization, and In Vitro Evaluation

被引:4
作者
Sateesha, S. B. [1 ]
Rao, B. Prakash [1 ]
Rajamma, A. J. [2 ]
Nargund, L. V. G. [3 ]
机构
[1] Acharya & BM Reddy Coll Pharm, Dept Pharmaceut, Bangalore 560090, Karnataka, India
[2] KLE Univ Coll Pharm, Dept Pharmacognosy, Bangalore 560010, Karnataka, India
[3] Nargund Coll Pharm, Dept Pharmachem, Bangalore 560085, Karnataka, India
来源
DISSOLUTION TECHNOLOGIES | 2011年 / 18卷 / 03期
关键词
CONTROLLED DRUG-DELIVERY; GASTRIC RETENTION; SYSTEMS;
D O I
10.14227/DT180311P72
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The present study involves the preparation and evaluation of floating microspheres of orlistat for improving drug bio-availability by prolongation of gastric residence time. The microspheres were prepared by a solvent diffusion-evaporation technique using inert polymers (Eudragit RL100, cellulose acetate, and ethyl cellulose). The effect of three formulation variables (i.e., drug/polymer ratio [DIP], polymer amount, and stirring speed) on floatability, encapsulation efficiency, percentage fines, and release mechanism were studied. The results of Fourier transform infrared spectroscopy show no interaction between the drug and the polymers. In vitro dissolution studies were performed in 0.1 N HCl (pH 1.2) for 12 h, and samples were analyzed by HPLC using a UV-vis detector at 205 nm. The grading curve was constructed for the selected formulations, and D(30), D(60), and D(90) values were determined to characterize the size distribution. A comparison of r(2) values for Higuchi, Korsmeyer-Peppas, and zero-order kinetic models for different batches of microspheres shows Fickian and non-Fickian diffusion kinetics. The orlistat microspheres prepared with cellulose acetate (DIP 1:2) at the stirring speed of 900 rpm show maximum floatability and optimum encapsulation efficiency, and exhibited a prolonged release for almost 12 h with a Fickian diffusion release mechanism.
引用
收藏
页码:72 / 79
页数:8
相关论文
共 24 条
[1]  
Al-Suwailem K., 2006, J APPL SCI RES, V2, P205
[2]   Importance of weight management in Type 2 diabetes: Review with meta-analysis of clinical studies [J].
Anderson, JW ;
Kendall, CWC ;
Jenkins, DJA .
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2003, 22 (05) :331-339
[3]   Floating drug delivery systems: A review [J].
Arora, S ;
Ali, J ;
Ahuja, A ;
Khar, RK ;
Baboota, S .
AAPS PHARMSCITECH, 2005, 6 (03) :E372-E390
[4]   Orlistat: its current status as an anti-obesity drug [J].
Ballinger, A ;
Peikin, SR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (2-3) :109-117
[5]  
Bougoulia Maria, 2006, Hormones (Athens), V5, P259
[6]  
Drew BS, 2007, VASC HEALTH RISK MAN, V3, P817
[7]  
Edlund U, 2002, ADV POLYM SCI, V157, P67
[8]   Preparation and evaluation of ketoprofen floating oral delivery system [J].
El-Kamel, AH ;
Sokar, MS ;
Al Gamal, SS ;
Naggar, VF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 220 (1-2) :13-21
[9]  
Gattani Y S., 2009, Int J ChemTech Res, V1, P1
[10]  
Gohel M.C., 2004, Disso Tech, V11, P22